These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7042558)

  • 41. [Cytogenetic effect of ethylenimine derivatives in cultures of human lymphocytes. I. Experimental findings and mathematical verification of quantitative patterns].
    Iakovenko KN; Azhaev SA; Bochkov NP
    Genetika; 1974; 10(10):135-43. PubMed ID: 4220049
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tet60 and Tet18h rosette tests in breast cancer or Hodgkin's disease and in healthy persons].
    Gasińska A; Smolak K
    Nowotwory; 1980; 30(2):161-6. PubMed ID: 6968061
    [No Abstract]   [Full Text] [Related]  

  • 43. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK; Gupta RK; Sadana JR
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mycosis surveillance of compromised patients by means of the E-rosette-test (author's transl)].
    Seebacher C; Bässler E
    Mykosen; 1981 Nov; 24(11):668-76. PubMed ID: 6976511
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cytogenetic effect of ethylenimine derivatives in human lymphocyte cultures. III. An analysis of the types of chromosome aberrations].
    Azhaev SA
    Genetika; 1974 Dec; 10(12):156-60. PubMed ID: 4220053
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bone marrow T-lymphocyte subpopulations in patients with multiple myeloma].
    Rizzo M; Meli C; Bonanno M; Maccarrone S; Guglielmo P
    Boll Soc Ital Biol Sper; 1981 Mar; 57(6):678-84. PubMed ID: 6973996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 48. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular co-operation in the production of human leucocyte inhibitory factor by lymphocyte subpopulations stimulated with antigens and allogeneic cells.
    Räsänen L
    Immunology; 1979 Aug; 37(4):715-21. PubMed ID: 387577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone).
    Luckenbach GA; Cortez-Campeao D; Modolell ML; Munder PG; Bicker U
    Exp Pathol; 1981; 19(1):37-48. PubMed ID: 7262272
    [No Abstract]   [Full Text] [Related]  

  • 53. [The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease].
    Plat M; Plat U; Fleischer J; Wolf H; Palitzsch M; Hofmann R; Reinhardt U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):87-95. PubMed ID: 2472333
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro response to rosette inhibition factor (RIF) and rosette restoring factor (RRF) of human lymphocyte after fractionation on a discontinuous density albumin gradient.
    Wieczorek Z; Skibiński G; Zwoliński J
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):481-6. PubMed ID: 117785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia.
    Carandente F; De Vecchi A; Halberg F; Cornélissen G; Dammacco F
    Chronobiologia; 1988; 15(1-2):61-85. PubMed ID: 3262046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular (T cell) immunity in the human newborn.
    Stiehm ER; Winter HS; Bryson YJ
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):814-21. PubMed ID: 159431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 58. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of thymosin on human blood lymphocytes in vitro].
    Kosmiadi GA; Grigor'eva MP; Korotaev GK; Il'intseva IE; Grigor'ev MIu
    Vopr Onkol; 1979; 25(10):7-11. PubMed ID: 315663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.